Amaryl M Forte 1 mg (Glimepiride/Metformin)

Description

Introduction

Amaryl M Forte 1 mg is a tablet containing glimepiride 1 mg and metformin hydrochloride 1000 mg. The metformin component is in prolonged release form. The combination is used to manage type 2 diabetes when diet, exercise and either glimepiride or metformin alone have not provided adequate blood glucose control.

Treatment is assessed through regular blood glucose monitoring and other diabetes checks. A healthcare professional determines whether the fixed amounts of the two ingredients are appropriate.

What Is It?

Amaryl M Forte 1 mg is an uncoated bilayer tablet taken by mouth. One layer provides prolonged release metformin. Glimepiride belongs to the sulfonylurea group of medicines, while metformin is a biguanide. The two ingredients have different actions on blood glucose.

The “1 mg” in the product name refers to glimepiride. Each tablet also contains 1000 mg of metformin hydrochloride. These amounts should be considered together when reviewing a treatment plan.

How Does It Work?

Glimepiride stimulates insulin release from the pancreas. Insulin helps body tissues take up glucose from the blood. This effect can also lower blood glucose too far, causing hypoglycaemia.

Metformin reduces glucose production by the liver and improves the body’s response to insulin. Together, the ingredients can improve glycaemic control when treatment with one ingredient alone is insufficient. The prolonged release formulation affects the release of metformin from the tablet; it does not remove the need for monitoring or precautions.

Common Uses

This combination is used for type 2 diabetes when diet, exercise and a single agent—glimepiride or metformin—have not achieved adequate glycaemic control. It is not indicated for type 1 diabetes. Diabetic ketoacidosis is a condition in which this product is contraindicated.

Blood glucose results and glycated haemoglobin, or HbA1c, can help a healthcare professional assess how well treatment is working. Changes in illness, eating patterns, activity or other medicines can affect glucose control.

Available Strengths

This family is available in 1 mg, 2 mg.

Key Features

• Each tablet contains glimepiride 1 mg and metformin hydrochloride 1000 mg.
• The metformin is in prolonged release form within an uncoated bilayer tablet.
• The tablet combines a sulfonylurea and a biguanide.
• It is an oral fixed combination for the stated type 2 diabetes indication.

Benefits

• The ingredients lower blood glucose through complementary mechanisms.
• Combination therapy can improve glycaemic control when either ingredient alone has not provided adequate control.
• A single tablet contains both specified ingredient amounts, where that fixed combination is clinically appropriate.

The response to treatment differs between people. These characteristics do not establish that the product is appropriate for every person with type 2 diabetes.

Possible Side Effects

• Glimepiride can cause hypoglycaemia. Symptoms may include hunger, sweating, shakiness, dizziness, headache, poor concentration or confusion. Severe episodes can involve loss of consciousness and require urgent medical attention.
• Nausea, vomiting, diarrhoea, abdominal pain and reduced appetite can occur, particularly when metformin treatment begins.
• A metallic taste, temporary changes in vision, rash, itching or weight gain may occur.
• Long-term metformin treatment may lower vitamin B12 levels, sometimes contributing to nerve symptoms.
• Lactic acidosis is a rare but serious risk associated with metformin, particularly when it accumulates because kidney function has worsened.

Unusual weakness, marked sleepiness, breathing difficulty or abdominal pain may be signs of a serious problem. Seek urgent medical attention if lactic acidosis or severe hypoglycaemia is suspected. An allergic reaction with breathing difficulty also needs urgent care.

Precautions

• Kidney function needs assessment before treatment and at intervals during treatment. Severe kidney impairment is a contraindication.
• Skipped meals, undernourishment, changes in activity and other glucose-lowering medicines can increase the risk of hypoglycaemia.
• Liver disease, conditions that reduce oxygen delivery to tissues and a history of metabolic acidosis require clinical review. Some of these conditions are contraindications.
• The combination is contraindicated during pregnancy and breastfeeding. Pregnancy plans should be discussed with a healthcare professional.
• Known hypersensitivity to glimepiride, metformin or tablet ingredients is a contraindication. Relevant sulfonylurea or sulfonamide allergy also needs review.

Additional Precautions

• Severe vomiting, diarrhoea, fever or poor fluid intake can cause dehydration and may increase the risk associated with metformin. Seek prompt medical advice during these illnesses.
• Tell the treating team about metformin before imaging with iodinated contrast or surgery requiring general, spinal or epidural anaesthesia. Treatment may need temporary interruption under clinical direction.
• Hypoglycaemia or high blood glucose can reduce alertness and affect driving or operating machinery.
• Vitamin B12 assessment may be relevant during long-term treatment, particularly if anaemia or nerve symptoms appear.
• There are insufficient data to recommend Amaryl M Forte for children.

Storage Instructions

• Store below 25°C.
• Protect the tablets from light and moisture.
• Keep them out of reach of children.
• Check the expiry date on the supplied pack before use.

How to Take

• Follow the schedule and amount prescribed by a healthcare professional. The fixed combination may need review if treatment requirements change.
• Swallow the tablet whole. Do not crush or chew it, because it contains prolonged release metformin.
• The product information describes administration with breakfast or the first main meal; the prescriber should confirm the individual schedule.
• Do not use a larger amount to make up for a missed tablet. Agree on a missed-dose plan with a healthcare professional.
• Continue the blood glucose checks recommended by the treating team so the response to treatment can be assessed.

Drug Interactions

• Insulin and other glucose-lowering medicines may increase the risk of hypoglycaemia.
• Medicines including fluconazole, clarithromycin and some other antimicrobials may increase glimepiride’s glucose-lowering effect.
• Corticosteroids, certain diuretics and some other medicines can raise blood glucose.
• Beta blockers may make some warning signs of hypoglycaemia less noticeable.
• Medicines that can impair kidney function, including some anti-inflammatory medicines and diuretics, may increase the risks associated with metformin.
• Excessive alcohol intake increases the risk of lactic acidosis and can affect glimepiride’s effect on blood glucose.

A healthcare professional should review prescription medicines, non-prescription medicines and supplements for possible interactions before or during treatment.

Why Choose This Product?

• It provides glimepiride 1 mg and prolonged release metformin hydrochloride 1000 mg in one tablet.
• Its two ingredients act in different ways to lower blood glucose.
• It is an option within its stated indication when a healthcare professional determines that both ingredient amounts are suitable.

A fixed combination limits independent adjustment of its ingredients. If the required amounts differ, a healthcare professional can assess other treatment options.

Frequently Asked Questions (FAQs)

What ingredients does Amaryl M Forte 1 mg contain?

Each tablet contains glimepiride 1 mg and metformin hydrochloride 1000 mg.

Which ingredient is prolonged release?

Metformin is the prolonged release component of the bilayer tablet.

What is the tablet used for?

It is used to manage type 2 diabetes when diet, exercise and either ingredient alone have not provided adequate glycaemic control.

Is it used for type 1 diabetes?

No. Its stated indication concerns type 2 diabetes.

Can the tablet be crushed or chewed?

No. The prolonged release tablet should be swallowed whole.

Can it cause low blood glucose?

Yes. Glimepiride can cause hypoglycaemia, which can sometimes be severe or prolonged.

Why is kidney function monitored?

Reduced kidney function can increase metformin accumulation and the risk of lactic acidosis.

What if a tablet is missed?

Do not compensate by taking a larger amount. Ask a healthcare professional for a missed-dose plan.

Can it be used during pregnancy or breastfeeding?

The combination is contraindicated during pregnancy and breastfeeding. A healthcare professional can discuss alternative management.

Does it replace diet and exercise?

No. Diet, physical activity and monitoring remain parts of type 2 diabetes care.

Related Products

• Amaryl M Forte 1 mg (Glimepiride/Metformin)
• Amaryl M Forte 2 mg (Glimepiride/Metformin)
• Bromocriptine 1.25 mg Australia
• Acarbose 50 mg Australia
• Repaglinide 0.5 mg Australia
• Sitagliptin 100 Mg Australia